This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hitomi, M.
Right arrow Articles by Stacey, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hitomi, M.
Right arrow Articles by Stacey, D. W.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, July 1999, p. 4623-4632, Vol. 19, No. 7
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Cellular Ras and Cyclin D1 Are Required during Different Cell Cycle Periods in Cycling NIH 3T3 Cells

Masahiro Hitomi and Dennis W. Stacey*

Department of Molecular Biology, The Lerner Research Institute, The Cleveland Clinic Foundation, Cleveland, Ohio 44195

Received 9 February 1999/Returned for modification 19 March 1999/Accepted 5 April 1999

Novel techniques were used to determine when in the cell cycle of proliferating NIH 3T3 cells cellular Ras and cyclin D1 are required. For comparison, in quiescent cells, all four of the inhibitors of cell cycle progression tested (anti-Ras, anti-cyclin D1, serum removal, and cycloheximide) became ineffective at essentially the same point in G1 phase, approximately 4 h prior to the beginning of DNA synthesis. To extend these studies to cycling cells, a time-lapse approach was used to determine the approximate cell cycle position of individual cells in an asynchronous culture at the time of inhibitor treatment and then to determine the effects of the inhibitor upon recipient cells. With this approach, anti-Ras antibody efficiently inhibited entry into S phase only when introduced into cells prior to the preceding mitosis, several hours before the beginning of S phase. Anti-cyclin D1, on the other hand, was an efficient inhibitor when introduced up until just before the initiation of DNA synthesis. Cycloheximide treatment, like anti-cyclin D1 microinjection, was inhibitory throughout G1 phase (which lasts a total of 4 to 5 h in these cells). Finally, serum removal blocked entry into S phase only during the first hour following mitosis. Kinetic analysis and a novel dual-labeling technique were used to confirm the differences in cell cycle requirements for Ras, cyclin D1, and cycloheximide. These studies demonstrate a fundamental difference in mitogenic signal transduction between quiescent and cycling NIH 3T3 cells and reveal a sequence of signaling events required for cell cycle progression in proliferating NIH 3T3 cells.


* Corresponding author. Mailing address: Department of Molecular Biology, NC2-151, The Lerner Research Institute, The Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH 44195. Phone: (216) 444-0633. Fax: (216) 444-0512. E-mail: staceyd{at}ccf.org.


Molecular and Cellular Biology, July 1999, p. 4623-4632, Vol. 19, No. 7
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Zhang, Y.-A., Nemunaitis, J., Samuel, S. K., Chen, P., Shen, Y., Tong, A. W. (2006). Antitumor Activity of an Oncolytic Adenovirus-Delivered Oncogene Small Interfering RNA. Cancer Res. 66: 9736-9743 [Abstract] [Full Text]  
  • Liu, F., Lee, W.-H. (2006). CtIP Activates Its Own and Cyclin D1 Promoters via the E2F/RB Pathway during G1/S Progression. Mol. Cell. Biol. 26: 3124-3134 [Abstract] [Full Text]  
  • Choudhuri, T., Pal, S., Das, T., Sa, G. (2005). Curcumin Selectively Induces Apoptosis in Deregulated Cyclin D1-expressed Cells at G2 Phase of Cell Cycle in a p53-dependent Manner. J. Biol. Chem. 280: 20059-20068 [Abstract] [Full Text]  
  • Shojaei, F., Gallacher, L., Bhatia, M. (2004). Differential gene expression of human stem progenitor cells derived from early stages of in utero human hematopoiesis. Blood 103: 2530-2540 [Abstract] [Full Text]  
  • Roberts, E. C., Shapiro, P. S., Nahreini, T. S., Pages, G., Pouyssegur, J., Ahn, N. G. (2002). Distinct Cell Cycle Timing Requirements for Extracellular Signal-Regulated Kinase and Phosphoinositide 3-Kinase Signaling Pathways in Somatic Cell Mitosis. Mol. Cell. Biol. 22: 7226-7241 [Abstract] [Full Text]  
  • Stacey, D. W., Hitomi, M., Chen, G. (2000). Influence of Cell Cycle and Oncogene Activity upon Topoisomerase IIalpha Expression and Drug Toxicity. Mol. Cell. Biol. 20: 9127-9137 [Abstract] [Full Text]  
  • Malumbres, M., Pérez De Castro, I., Hernández, M. I., Jiménez, M., Corral, T., Pellicer, A. (2000). Cellular Response to Oncogenic Ras Involves Induction of the Cdk4 and Cdk6 Inhibitor p15INK4b. Mol. Cell. Biol. 20: 2915-2925 [Abstract] [Full Text]